Month: July 2024

  • Comprehensive Analysis On Size, Share, And Drivers Of The Speech Impairment Market

    Comprehensive Analysis On Size, Share, And Drivers Of The Speech Impairment Market

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

     Market Expansion Overview

    • 2023 Market Size: $9.34 billion
    • 2024 Market Size: $10.03 billion
    • CAGR: 7.4%

    The speech impairment market has experienced robust growth recently, driven by a rising geriatric population, increased awareness of cognitive health and speech connections, lifestyle changes, advances in artificial intelligence (AI), and an aging population.

    Future Market Projections

    • 2028 Market Size: $12.73 billion
    • CAGR: 6.1%

    Continued growth is expected due to increased awareness about speech impairments, rising incidence of speech disorders, the rise of mobile health applications, adoption of augmentative and alternative communication (AAC) devices, and demand for speech therapy and pathology services. Key trends include advancements in speech recognition, healthcare-technology collaborations, home-based interventions, and speech-to-text innovations.

    View More On The Speech Impairment Market Report 2024 – https://www.thebusinessresearchcompany.com/report/speech-impairment-global-market-report

    Focus on Early Detection and Advanced Solutions

    • Rising Incidence of Speech Disorders: Significant increases in diagnoses among children post-pandemic

    The increasing incidence of speech disorders is propelling market growth. Effective diagnostic tools, therapies, and assistive technologies are in high demand. For example, Contemporary Pediatrics reported a 136% increase in speech disorder diagnoses among infants and children aged 0-2 in 2022 compared to pre-pandemic levels, with children aged 3-5 seeing a 107% increase.

    Key Market Players

    • Major Companies: Google LLC, Microsoft Corporation, The International Business Machines Corporation, LifePoint Health, Sunnova Holding AG, Open Text Corporation, Nuance Communications Inc., Reliant Rehabilitation, Therapy Solutions Inc., Benchmark Physical Therapy Institute, Tobii Dynamo, Humanos Corporation, Pitmatics, Nongraphical, Capela Group, Read Speaker, John McGivney Children’s Centre, Rehabilitation Associates Inc., Able Net Inc., Saltillo Corporation, Lumen Vox LLC, Assistive Ware, Speak AI, Cognition

    Speech Recognition Apps: Transforming Communication

    • Innovative Technology Example: Violet app by Violet (June 2021)

    Companies are leveraging speech recognition apps to aid communication for individuals with speech impairments. The Violet app, launched by an Israeli startup, uses patented automatic speech recognition (ASR) technology to understand non-standard speech and convert it into text and voice output, specifically catering to individuals with motor-speech disabilities, aging voices, and accents.

    Expansion Through Acquisitions

    • Notable Acquisition: Rethink First acquires Total Therapy (January 2022)

    Rethink First expanded its behavioral health technology portfolio by acquiring Total Therapy, enhancing its offerings in speech, occupational, and physical therapy markets. This acquisition enables Rethink First to provide a comprehensive suite of solutions for its customers.

    Market Segmentation

    • By Type: Speech Disorder, Language Disorder, Apraxia, Autism Spectrum Disorder (ASD), Other Types
    • By Age: Pediatrics, Adults, Elderly
    • By End-User: Specialty Clinics, Rehabilitation Centers, Speech Therapy Centers, Bilingual Classes, Hospitals, Community Health Centers

    Regional Insights

    • Largest Market in 2023: North America
    • Fastest-Growing Region: Asia-Pacific (forecast period)

    The speech impairment market is segmented by type, age, and end-user, with North America leading in market size in 2023. Asia-Pacific is anticipated to be the fastest-growing region due to increasing awareness and adoption of advanced therapies and technologies.

    Request A Sample Of The Global Speech Impairment Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13935&type=smp

  • Key Insights On The Smart Portable Rehabilitation Devices Market 2024 – Size, Driver, And Major Players

    Key Insights On The Smart Portable Rehabilitation Devices Market 2024 – Size, Driver, And Major Players

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Smart Portable Rehabilitation Devices Global Market Report 2024, the smart portable rehabilitation devices market is expected to show significant growth in the forecast period.

    Market Expansion Overview

    • 2023 Market Size: $2.49 billion
    • 2024 Market Size: $2.88 billion
    • CAGR: 15.6%

    The smart portable rehabilitation devices market has experienced substantial growth recently, driven by increasing disability cases, the adoption of virtual reality (VR) technology in healthcare, and the rising use of VR for patient treatment.

    Future Market Projections

    • 2028 Market Size: $5.08 billion
    • CAGR: 15.3%

    The market is poised for rapid growth, fueled by an aging population, higher prevalence of non-communicable diseases, supportive virtual rehabilitation policies, and a stronger focus on patient-centric healthcare. Trends include product innovations, technological advancements, and improved internet connectivity.

    View More On The Smart Portable Rehabilitation Devices Market Report 2024 – https://www.thebusinessresearchcompany.com/report/smart-portable-rehabilitation-devices-global-market-report

    Geriatric Population Impact

    • Geriatric Population Growth: Expected to reach 2.1 billion by 2050

    The increasing elderly population drives market expansion. Smart portable rehabilitation devices help senior citizens maintain independence by enabling health monitoring and self-paced rehabilitation. WHO data indicates a rise from 1.4 billion individuals aged 60 and over in 2022 to 2.1 billion by 2050.

    Key Market Players

    • Major Companies: Medline Industries Inc., Invacare Corporation, Caremax Rehabilitation Equipment Ltd, Hinge Health, Drive Devilbiss Healthcare, Kinova Robotics, GF Health Products Inc., Dynatronics Corporation, Bioness Inc., Motion Composites, MindMaze, Neofect, Hocoma, Tyromotion, Myomo Inc., Esko Bionics, AlterG, ReWalk Robotics, LiteGait, suitX, Rifton Equipment, InnoMotion, Reha Technology AG, Rex Bionics, Kinestica, Ankon Medical Technologies, DyCare, Bionik Laboratories.

    Strategic Partnerships

    • Example Partnership: Manipal Hospitals and ConnectedLife (March 2022)

    Companies are forming strategic partnerships to enhance market competitiveness. Manipal Hospitals partnered with ConnectedLife to use Fitbit wearable technology for post-surgery rehabilitation. This collaboration enables remote monitoring and patient guidance, using devices to track vital signs and recovery metrics.

    Mergers and Acquisitions

    • Notable Merger: DIH Technology and Aurora Technology Acquisition Corp. (December 2022)

    The merger of DIH Technology and Aurora Technology Acquisition Corp. aims to revolutionize rehabilitation devices by integrating robotics, augmented reality, virtual reality, and AI, leading to more effective and personalized treatment plans.

    Market Segmentation

    • By Type: Daily Living Aids, Mobility Equipment, Exercise Equipment, Body Support Devices
    • By Rehabilitation Type: Passive Rehabilitation, Active-Assistive Rehabilitation
    • By End-User: Hospitals and Clinics, Rehabilitation Centers, Physiotherapy Centers, Other End-Users

    Regional Insights

    • Largest Market in 2023: North America

    The smart portable rehabilitation devices market is segmented by type, rehabilitation type, and end-user, with North America leading in market size as of 2023. The region’s advanced healthcare infrastructure and high adoption rate of new technologies contribute to its dominant market position.

    Request A Sample Of The Global Smart Portable Rehabilitation Devices Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13934&type=smp

  • Global Healthcare Cybersecurity Market Overview 2024: Size, Drivers, And Trends

    Global Healthcare Cybersecurity Market Overview 2024: Size, Drivers, And Trends

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

     Impressive Historical Growth

    • Market Size: Increased from $20.59 billion in 2023 to $23.86 billion in 2024.
    • CAGR: 15.9%.
    • Key Drivers:
      • Increased cyberattacks.
      • Growing concerns about security and privacy.
      • Collaboration between public and private sectors to strengthen cybersecurity.
      • Highly developed medical and healthcare infrastructure.
      • Emergence of digital technologies.

    Strong Future Outlook

    • Expected Growth: Projected to reach $42.59 billion by 2028.
    • CAGR: 15.6%.
    • Key Drivers:
      • Increasing investments in cybersecurity by healthcare organizations and government initiatives.
      • Rising demand for advanced cybersecurity solutions and privacy.
      • Increased frequency and complexity of cyber threats.
      • Rising security and regulatory compliance-related issues.
      • Increasing network vulnerabilities.

    View More On The Healthcare Cybersecurity Market Report 2024 – https://www.thebusinessresearchcompany.com/report/healthcare-cybersecurity-global-market-report

    Key Trends Shaping the Future

    • Trends:
      • Growth in adoption of IoT and connected devices.
      • Increased usage of cloud-based healthcare solutions.
      • Growing use of healthcare IT solutions in outpatient care facilities.
      • Rise in adoption of connected devices and smartphones.
      • Adoption of 5G technology.
      • Increased digitalization and adoption of Electronic Health Records (EHRs).
      • Use of wireless medical devices and telemedicine.

    Rise of Cybersecurity Needs Due to Increasing Cyber Threats

    • Increasing Cyberattacks:
      • Cyberattacks are malicious attempts to disrupt, damage, or gain unauthorized access to computer systems, networks, or devices.
      • Motivated by financial incentives, cybercriminals seek to steal sensitive financial information, conduct ransom attacks, or engage in other activities to monetize their attacks.
    • Importance of Healthcare Cybersecurity:
      • Essential for protecting sensitive patient data, ensuring continuity of care, and safeguarding healthcare systems.
      • Protects against data breaches, financial loss, and compromised patient safety.
    • Statistics: According to Check Point Software Technologies Ltd., in the first nine months of 2023, there was a 3% increase in the global average of weekly cyberattacks compared to 2022, with the healthcare sector experiencing an 11% rise, averaging 1,613 incidents weekly.

    Major Players in the Healthcare Cybersecurity Market

    • Key Companies:
      • Microsoft Corporation
      • Intel Corporation
      • International Business Machines Corporation
      • Cisco Systems Inc.
      • Broadcom Inc.
      • Thales Group
      • Palo Alto Networks Inc.
      • Juniper Networks Inc.
      • Fortinet Inc.
      • Gen Digital Inc.
      • Splunk Inc.
      • Check Point Software Technologies Ltd.
      • Trend Micro Inc.
      • CrowdStrike Holdings Inc.

    Advancements in Healthcare Cybersecurity with Medical IoT Security Solutions

    • IoT Security Solutions:
      • Strategies and technologies designed to protect connected medical devices and systems from cyber threats and unauthorized access.
    • Example: In December 2022, Palo Alto Networks Inc. launched Medical IoT Security, a zero-trust security system for healthcare devices featuring automatic discovery, segmentation, policy enforcement, and advanced threat protection. The solution leverages machine learning to identify threats, secure interactions, and integrate seamlessly with healthcare systems, ensuring rapid deployment and flexible architecture compatibility.

    Strategic Acquisitions to Strengthen Cybersecurity Offerings

    • Forescout Technologies: Acquired CyberMDX in October 2022 to enhance its cybersecurity offerings in healthcare.
      • Objective: Integrate CyberMDX’s expertise in the Internet of Medical Things (IoMT) to provide a holistic security solution across IT, IoT, OT, and IoMT domains against evolving threats.
      • CyberMDX: US-based healthcare cybersecurity provider.

    Market Segmentation

    • By Solution:
      • Identity and Access Management
      • Risk and Compliance Management
      • Antivirus and Antimalware
      • Distributed Denial of Service (DDoS) Mitigation
      • Security Information and Event Management
      • Intrusion Detection System/Intrusion Prevention System
      • Other Solutions.
    • By Security:
      • Network Security
      • Endpoint Security
      • Application Security
      • Content Security.
    • By Threat:
      • Malware
      • Distributed Denial of Service (DDoS) Threats
      • Advanced Persistent Threat
      • Spyware
      • Lost or Stolen Devices
      • Other Threats.
    • By End User:
      • Pharma and Chemicals
      • Medical Devices
      • Health Insurance
      • Hospitals
      • Other End Users.

    Regional Insights

    • Largest Region (2023): North America.
    • Fastest-Growing Region (Forecast Period): Asia-Pacific.

    Request A Sample Of The Global Healthcare Cybersecurity Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13964&type=smp

  • Global Artificial Tears Market Key Insights 2024-2033

    Global Artificial Tears Market Key Insights 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Artificial Tears Global Market Report 2024, the artificial tears market is expected to show promising growth in the forecast period.

    The artificial tears market has shown significant growth and is poised for further expansion in the coming years. Here’s an in-depth look at the key factors driving this growth, major trends, and notable industry developments.

    Market Growth Overview

    Strong Historic Growth

    • Market size in 2023: $3.32 billion
    • Projected market size in 2024: $3.55 billion
    • CAGR: 6.7%

    Factors driving growth:

    • Aging population
    • Prolonged screen time
    • Increased healthcare expenditure
    • Shift from prescription to over-the-counter (OTC) products
    • Regulatory changes

    Future Market Projections

    Continued Expansion

    • Projected market size in 2028: $4.55 billion
    • CAGR: 6.4%

    Growth drivers:

    • Increasing prevalence of dry eye syndrome
    • Growth in contact lens usage
    • Global urbanization
    • Rising pollution levels
    • E-commerce growth

    Major trends:

    • Technological advancements
    • AI and tech integration
    • Partnerships with healthcare providers
    • Use of natural ingredients
    • Advances in product formulation
    • Advanced drug delivery systems
    • Sustainable and eco-friendly products

    View More On The Artificial Tears Market Report 2024 – https://www.thebusinessresearchcompany.com/report/artificial-tears-global-market-report

    Impact of Dry Eye Disease Prevalence

    Increasing Dry Eye Cases

    • Dry eye disease is becoming more common, necessitating the use of artificial tears.
    • Dry eye disease causes discomfort due to insufficient or poor-quality tear production.
    • Artificial tears help alleviate symptoms by supplementing natural tear production.

    Survey Insights:

    • In a 2022 survey by Macquarie University, 13% of individuals aged 50+ showed clinical signs of dry eye disease.
    • Eyes On Eyecare reported a rise in prescription treatments for dry eye from 5.8% in 2021 to 7.56% in 2022.

    Key Players in the Market

    Major Companies

    • Pfizer Inc.
    • Johnson & Johnson
    • AbbVie Inc.
    • Novartis AG
    • Abbott Laboratories
    • Otsuka Pharmaceutical Co. Ltd.
    • Alcon
    • Bausch Health Companies Inc.
    • Sun Pharmaceutical Industries Ltd.
    • Reddy’s Laboratories
    • Santen Pharmaceutical Co. Ltd.
    • Lupin Limited
    • Rohto Pharmaceutical Co. Ltd.
    • Prestige Consumer Healthcare Inc.
    • Thea Pharma Inc.
    • OPTIMA pharma GmbH
    • Velocity Pharma LLC

    Technological Innovations

    HydroBoost and PureFlow Bottle Technology

    • Companies are incorporating technologies like HydroBoost and PureFlow to enhance product efficacy and user convenience.
    • Example:In April 2021, Alcon launched Systane Hydration Multi-Dose Preservative-Free Lubricant Eye Drops with HydroBoost Technology and PureFlow bottle for better hydration and sterility.

    Strategic Acquisitions

    Bausch + Lomb’s Acquisition of Blink

    • In July 2023, Bausch + Lomb acquired Blink products from Johnson & Johnson for $106.5 million.
    • This acquisition aims to expand Bausch + Lomb’s OTC eye care portfolio, providing consumers with more comprehensive eye care solutions.

    Market Segmentation

    Types of Artificial Tears

    • Glycerin Tears
    • Cellulose Tears
    • Oil-Based Emulsion Tears
    • Polyethylene Glycol-based Tears
    • Sodium Hyaluronate Based Artificial Tears
    • Propylene Glycol-based Tears

    Dosage Forms

    • Suspensions
    • Solution
    • Ointment
    • Emulsion
    • Gel
    • Spray

    Indications

    • Dry Eye Syndrome
    • Allergies
    • Infections
    • UV and Blue Light Protection
    • Contact Lens Moisture Retention
    • Other Indications

    Distribution Channels

    • Retail Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies
    • Ophthalmic Stores

    Regional Insights

    Geographic Trends

    • North America was the largest region in the artificial tears market in 2023.
    • Asia-Pacific is expected to be the fastest-growing region during the forecast period.

    With the increasing prevalence of dry eye syndrome and ongoing technological advancements, the artificial tears market is set to witness robust growth, offering improved solutions for those suffering from dry eye conditions.

    Request A Sample Of The Global Artificial Tears Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13799&type=smp

  • Global Bone Void Fillers Market Analysis: Estimated Market Size And Growth Rate

    Global Bone Void Fillers Market Analysis: Estimated Market Size And Growth Rate

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    Market Overview

    • Market Size (2023-2024): The bone void fillers market size is experiencing robust growth, increasing from $3.26 billion in 2023 to $3.53 billion in 2024, with a compound annual growth rate (CAGR) of 8.1%.
    • Historic Growth Drivers: Factors such as the rising prevalence of bone-related diseases, an aging population, sports injuries, increasing healthcare expenditures, and funding from private and government organizations have fueled market growth in recent years.

    Future Market Projections

    • Market Size (2024-2028): The market is projected to grow to $4.58 billion by 2028, with a CAGR of 6.7%.
    • Forecast Period Growth Drivers: Key drivers include expanding applications in regenerative medicine, increased incidence of lifestyle diseases, a rise in orthopedic surgeries, greater adoption of minimally invasive surgical techniques, and the emergence of personalized medicine and tailored treatments.

    View More On The Bone Void Fillers Market Report 2024 – https://www.thebusinessresearchcompany.com/report/bone-void-fillers-global-market-report

    Trends Shaping the Future

    • Medical Technology Advancements: Innovations in medical technology and biocompatibility are set to drive the market.
    • Customization and 3D Printing: Customization of bone void fillers through 3D printing technology is becoming more prevalent.
    • Surgical Procedure Advancements: Technological advancements in surgical procedures, imaging, and surgical planning are enhancing the effectiveness of treatments.

    Growing Burden of Bone Diseases

    • Impact on Market: The increasing burden of bone diseases is expected to propel the market growth of bone void fillers.
    • Disease Statistics: According to the Institute for Health Metrics and Evaluation (IHME), nearly 1 billion individuals are projected to suffer from osteoarthritis by 2050, with knee osteoarthritis expected to rise by 75% and hand osteoarthritis by 50%.

    Leading Companies in the Market

    • Key Players: Major companies in the market include Johnson & Johnson, Medtronic plc, Danaher Corporation, Heraeus Group, Stryker Corporation, Baxter International Inc., B. Braun Melsungen AG, Huntsman Corporation, Zimmer Biomet Holdings Inc., and many others.

    Advancements in Bone Healing Through Carbohydrate Polymer Technologies

    • Innovative Products: Companies are developing innovative products like carbohydrate polymer bone graft substitutes to enhance market profitability.
    • Example Product: In May 2023, Royal Biologics launched Bio-Reign 3D, a bone graft substitute made from hyper-crosslinked natural carbohydrate polymer. It provides an optimal environment for cell growth and bone regeneration, transitioning from radiolucent to radiopaque as healing progresses.

    Henry Schein Expands Capabilities

    • Strategic Acquisition: In April 2023, Henry Schein Inc. acquired a majority stake in Biotech Dental SAS, aiming to enhance digital integration between Biotech Dental’s software and its product suite, driving global expansion in the implant and orthodontics sectors.

    Market Segmentation

    • By Type: Demineralized Bone Matrix, Calcium Phosphate Bone Graft Substitute, Collagen Matrix, Other Types.
    • By Form: Gel and Putty, Granules, Other Forms.
    • By Application: Bone Fracture, Spine Fusion, Other Applications.
    • By End-User: Hospitals, Specialty Clinics.

    Regional Insights

    • Largest Region: North America was the largest region in the bone void fillers market in 2023, driven by advanced healthcare infrastructure and high adoption rates of innovative medical technologies.

    The bone void fillers market is set for continued growth, driven by technological advancements, increasing demand for minimally invasive procedures, and a rising prevalence of bone-related conditions. With key players investing in innovative products and strategic acquisitions, the market is poised for significant developments in the coming years.

    Request A Sample Of The Global Bone Void Fillers Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13815&type=smp

  • Key Trends And Drivers In The Bronchodilators Market 2024

    Key Trends And Drivers In The Bronchodilators Market 2024

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    Impressive Historical Growth

    • Market Size: Increased from $30.43 billion in 2023 to $32.93 billion in 2024.
    • CAGR: 8.2%.
    • Key Drivers:
      • Growing geriatric population.
      • Rising incidence of asthma.
      • Increased funding by government organizations.
      • Aging population.
      • Increasing air pollution worldwide.

    Strong Future Outlook

    • Expected Growth: Projected to reach $43.25 billion by 2028.
    • CAGR: 7.0%.
    • Key Drivers:
      • Increasing prevalence of COPD.
      • Rising awareness about lung disease treatments.
      • Escalating research and development efforts.
      • Increased prevalence of pulmonary disorders.
      • Rising disposable income.
      • Increasing smoking rates.

    Read More On The Bronchodilators Market Report 2024 – https://www.thebusinessresearchcompany.com/report/bronchodilators-global-market-report

    Key Trends Shaping the Future

    • Trends:
      • Advanced clinical research and innovative strategies.
      • Growing technological advancements.
      • High prevalence of lung diseases such as COPD and asthma.
      • New product launches.
      • Rising number of patients with acute respiratory infections.

    Rising COPD Prevalence Fuels Growth in Bronchodilator Market

    • Increasing Prevalence of COPD:
      • Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by chronic inflammation of the airways and obstruction or limitation of airflow.
      • Bronchodilators are used in COPD to relax the muscles around the airways, helping to open them and make it easier to breathe.
    • Statistics: According to a report by the Scottish Public Health Observatory, COPD rates increased in males from 83.2 to 97.6 cases per 100,000, and in females from 72.6 to 97.3 as the impact of COVID-19 eased in March 2023.

    Major Players in the Bronchodilators Market

    • Key Companies:
      • Pfizer Inc.
      • Johnson & Johnson Services Inc.
      • Hoffmann-La Roche Ltd.
      • Bayer AG
      • Novartis AG
      • Thermo Fisher Scientific
      • Abbott Laboratories
      • Sanofi S.A.
      • GlaxoSmithKline plc
      • Siemens Healthcare GmbH
      • Merck & Co. Inc.
      • AstraZeneca plc
      • Teva Pharmaceuticals Industries Ltd.
      • Mylan N.V.
      • Quest Diagnostics Incorporated.
      • Boehringer Ingelheim International GmbH

    Lupin Introduces DIFIZMA: A Groundbreaking Fixed-Dose Triple Drug Combination

    • Innovative Product Launch:
      • Major companies in the bronchodilator market are developing innovative products like fixed-dose triple-drug combinations.
      • Example: In January 2023, Lupin launched DIFIZMA, a fixed-dose triple-drug bronchodilator with a combination of indacaterol, glycopyrronium, and mometasone for managing asthma.
      • DIFIZMA is offered as a dry powder inhalation and is the only fixed-dose combination approved by the Drug Controller General of India (DCGI) for treating inadequately controlled asthma by improving lung function, providing better symptom control, and reducing exacerbations.

    AstraZeneca’s Focus on Bronchodilator Products Through CinCor Pharma Acquisition

    • Strategic Acquisition:
      • In February 2023, AstraZeneca plc acquired CinCor Pharma Inc. for $1.8 billion.
      • Objective: Develop novel treatments for uncontrolled hypertension and chronic kidney disease and strengthen AstraZeneca’s respiratory portfolio, which includes several bronchodilator products.
      • CinCor Pharma: A US-based clinical-stage biopharmaceutical company involved in the development of bronchodilator-related products.

    Market Segmentation

    • By Type:
      • Beta-Adrenergic Bronchodilators
      • Anticholinergic Bronchodilators
      • Xanthine Derivatives
      • Other Types.
    • By Route of Administration:
      • Oral
      • Nasal (Inhalation)
    • By Indication:
      • Asthma
      • Chronic Obstructive Pulmonary Disease (COPD)
      • Allergic Reactions
      • Breathing Problem
      • Other Indications.
    • By End User:
      • Hospitals
      • Specialty Clinics
      • Other End Users.

    Regional Insights

    • Largest Region (2023): North America.
    • Fastest-Growing Region (Forecast Period): Asia-Pacific.

    Request for A Sample Of The Global Bronchodilators Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=13816&type=smp

  • Understand How The Clinical Data Management Systems (CDMS) Market Is Poised To Grow Through 2024-2033

    Understand How The Clinical Data Management Systems (CDMS) Market Is Poised To Grow Through 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    As per The Business Research Company’s Clinical Data Management Systems (CDMS) Global Market Report 2024, the clinical data management systems (CDMS) market is expected to show significant growth in the forecast period.

    Market Growth Overview

    • Rapid Growth: The clinical data management systems (CDMS) market has experienced significant growth, expanding from $2.53 billion in 2023 to $2.89 billion in 2024, with a compound annual growth rate (CAGR) of 13.8%.
    • Historic Drivers: Key factors contributing to this growth include stringent regulatory requirements, an increasing volume of clinical data, a focus on data accuracy and quality, a rise in multicenter clinical trials, and increased outsourcing of clinical trials.

    Future Market Projections

    • Continued Expansion: The CDMS market is expected to continue its rapid growth, reaching $4.74 billion by 2028, with a CAGR of 13.2%.
    • Forecast Drivers: This growth will be driven by the adoption of risk-based monitoring, patient-centric trial designs, the increased use of real-world evidence (RWE), the globalization of clinical trials, a focus on interoperability, and an emphasis on decentralized and virtual trials.
    • Emerging Trends: Major trends include the integration with electronic health records (EHR), the use of artificial intelligence in data analysis, risk-based monitoring, mobile health (mHealth) integration, and compliance with data privacy regulations.

    View More On The Clinical Data Management Systems (CDMS) Market Report 2024 – https://www.thebusinessresearchcompany.com/report/clinical-data-management-systems-cdms-global-market-report

    Evolving Role of CDMS in Clinical Trials

    • Enhanced Research Reliability: The increasing volume and complexity of clinical trials are expected to propel the growth of the CDMS market. Clinical data management systems ensure accurate data collection, integration, and availability for analysis, enhancing the reliability and speed of research findings.
    • Volume Increase: According to ClinicalTrials.gov, the number of clinical trials publishing findings increased from 4,024 in 2022 to 5,063 in 2023, highlighting the growing demand for robust CDMS solutions.

    Key Market Players

    • Major Companies: Key players in the CDMS market include Oracle Corporation, IQVIA Inc., Dassault Systèmes SE, PAREXEL International Corporation, Epic Systems Corporation, Veeva Systems Inc., Medical Information Technology Inc.

    Technological Advancements

    • Health Intelligence Platforms: Companies in the CDMS market are focusing on developing new technologies, such as health intelligence platforms, to enhance their market profitability. These platforms leverage data analytics and artificial intelligence to improve efficiency, accuracy, and insights from clinical trial data.
    • Orion Health’s Orchestral: In April 2023, Orion Health Group Limited launched Orchestral, a versatile health intelligence platform that supports cloud or on-premises setups, integrating advanced features such as machine learning, natural language processing (NLP), and seamless data integration.

    Strategic Acquisitions

    • Ennov Group’s MACRO Acquisition: In April 2022, Ennov Group acquired MACRO from Elsevier to enhance its suite of life sciences software with advanced electronic data capture (EDC) tools, aiming to provide a comprehensive and cost-efficient solution for clinical research.

    Market Segmentation

    • By Type: The CDMS market is segmented into paper-based systems, electronic data capturing systems, and hybrid systems.
    • By Component: Segmentation includes software and services.
    • By Deployment: The market is divided into on-premise and cloud-based systems.
    • By End Use: Key end-users include contract research organizations (CROs), medical device companies, pharma/biotech companies, and other end uses.

    Regional Insights

    • North America: In 2023, North America was the largest region in the clinical data management systems market, driven by advanced healthcare infrastructure and a high volume of clinical trials.

    Request A Sample Of The Global Clinical Data Management Systems (CDMS) Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13961&type=smp

  • Aortic Endograft Market Growth Analysis Till 2033 By The Business Research Company

    Aortic Endograft Market Growth Analysis Till 2033 By The Business Research Company

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    Strong Historical Growth

    • Market Size: Grew from $3.14 billion in 2023 to $3.35 billion in 2024.
    • CAGR: 6.7%.
    • Key Drivers:
      • Growth in medical tourism.
      • Increasing need for aortic aneurysm management.
      • Rising number of aortic aneurysm cases.
      • Technical success of endograft implantation.
      • Increase in the number of hospitals.

    Promising Future Outlook

    • Expected Growth: Projected to reach $4.08 billion by 2028.
    • CAGR: 5.1%.
    • Key Drivers:
      • Increasing prevalence of abdominal aortic aneurysm.
      • Growing preference for minimally invasive procedures.
      • Rising geriatric population.
      • Advancements in stent-graft materials and configurations.
      • Introduction of new stent-graft products.

    Read More On The Aortic Endograft Market Report 2024 – https://www.thebusinessresearchcompany.com/report/aortic-endograft-global-market-report

    Market Trends and Innovations

    • Trends:
      • Adoption of endovascular abdominal aortic aneurysm (AAA) repair devices.
      • Effectiveness of unibody and non-unibody aortic stents.
      • Product innovation.

    Rising Incidence of Aortic Aneurysms

    • Aortic Aneurysms: Localized dilation or bulging of the aorta.
    • Treatment: Aortic endografts are less invasive than traditional surgery, involving a fabric-covered metal or polymer device inserted via a catheter.
    • Screening Statistics: In the UK, 274,800 men were screened between April 2021 and March 2022, identifying 1,794 aneurysms.

    Key Players in the Market

    • Major Companies:
      • Cardinal Health Inc.
      • Abbott Laboratories
      • Medtronic Plc
      • Becton, Dickinson and Company
      • Koninklijke Philips N.V.
      • Boston Scientific Corporation
      • Terumo Corporation
      • W. L. Gore & Associates Inc.
      • Cook Medical Inc.
      • Merit Medical Systems Inc.
      • Penumbra Inc.
      • LifeTech Scientific Corporation
      • Altura Medical Inc.
      • MicroVention Inc.
      • MicroPort Scientific Corporation
      • CryoLife Inc.
      • Cordis Corporation
      • Endologix LLC

    Innovations in Medical Devices

    • Castor-Branched Aortic Stent Graft System:
      • Manufacturer: Shanghai MicroPort Endovascular MedTech Group Co. Ltd.
      • Launch: December 2021.
      • Features: Minimally invasive repair of aorta and aortic arch, especially in Stanford type B aortic dissection (TBAD). Unique unibody design conforming to diverse arch anatomies, offering one-time access and release, and promoting long-term stability.

    Strategic Acquisitions

    • Endologix LLC: Acquired PQ Bypass Inc. in April 2021.
      • Objective: Expand and reinforce its position in abdominal aortic aneurysm treatment.
      • PQ Bypass Inc.: US-based medical device company specializing in aortic endografts.

    Market Segmentation

    • By Product:
      • Abdominal Aortic Grafts.
      • Thoracic Aortic Grafts.
    • By Material:
      • Metallic Endografts.
      • Polymeric Endografts.
    • By Procedure:
      • Open Surgical Repair.
      • Endovascular Aneurysm Repair (EVAR).
    • By End User:
      • Hospitals.
      • Ambulatory Surgical Centers.

    Regional Insights

    • Largest Region (2023): North America.
    • Fastest-Growing Region (Forecast Period): Asia-Pacific.

    Request for A Sample Of The Global Aortic Endograft Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=13784&type=smp

  • Growth Trajectory Of The Antibody Discovery Market 2024-2033

    Growth Trajectory Of The Antibody Discovery Market 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    Market Overview

    • Current Market Size: Grew from $8.09 billion in 2023 to $8.96 billion in 2024.
    • Growth Rate: Compound annual growth rate (CAGR) of 10.7%.
    • Historic Growth Drivers:
      • Increased investment in drug discovery.
      • Growth in research and development activities.
      • Presence of healthcare research centers and academic institutions.

    Future Market Projections

    • Expected Market Size: Projected to reach $13.21 billion by 2028.
    • Future Growth Rate: CAGR of 10.2%.
    • Future Growth Drivers:
      • Rising demand for antibody drug discovery services and platforms.
      • Increased funding for novel technology development.
      • Growing demand for precision therapeutics.
      • Broader use of antibodies beyond conventional therapeutic roles.

    View More On The Antibody Discovery Market Report 2024 – https://www.thebusinessresearchcompany.com/report/antibody-discovery-global-market-report

    Key Market Trends

    • R&D Activities: Surge in research and development.
    • Monoclonal Antibodies: Growing demand for monoclonal antibodies.
    • Advanced Technologies: Increased adoption of advanced technologies.
    • Targeted Therapeutics: Rising demand for targeted therapeutics.
    • Novel Antibody Formats: Development of new antibody formats.

    Precision Therapeutics: Driving Market Growth

    • Customization: Tailored medical treatments for individual patient characteristics.
    • Targeted Therapies: Development of monoclonal antibodies for specific disease-related molecules or cells.
    • FDA Approvals: In 2022, 34% of new molecular entities were classified as personalized medicines by the Personalized Medicine Coalition.
    • Impact: The growing need for precision therapeutics is a significant market driver.

    Major Players in the Market

    • Companies: Danaher Corporation, Eurofins Scientific, Sartorius AG, Charles River Laboratories, Bruker Corporation, WuXi Biologics, Genmab A/S, Evotec, Cambrex Corporation, ChemPartner, Aragen Life Science Pvt Ltd, Genscript Technology Corporation, Biocytogen, Alcami Corporation Inc, Twist Bioscience, BioDuro-Sundia.

    AI-Powered Platforms Revolutionizing Therapeutic Development

    • Innovative Technologies: Companies developing AI-based computational antibody drug discovery platforms.
    • Efficiency and Precision: AI expedites the identification and optimization of therapeutic antibodies.
    • Case Study:
      • SwiftPharma BV: Introduced an AI-driven antibody discovery platform in October 2023.
      • Technologies Used: Combines AI, big data, machine learning, and phage display.
      • Benefits: Rapid prediction of high-specificity and high-affinity antibody-antigen binding.

    Strategic Acquisitions Enhancing Market Capabilities

    • Twist Bioscience Acquisition of Abveris:
      • Date: November 2021.
      • Impact: Enhanced Twist’s biopharmacy antibody capabilities, particularly in mouse-based discovery and screening.
      • Abveris: A US-based antibody discovery services company.

    Market Segmentation

    • By Methods: Phage Display, Hybridoma, Other Methods.
    • By Antibody Type: Humanized Antibody, Human Antibody, Chimeric Antibody, Murine Antibody.
    • By End Users: Pharmaceutical and Biotechnology Industry, Research Laboratory, Academic Laboratory.

    Regional Insights

    • Largest Region: North America dominated the market in 2023.
    • Fastest-Growing Region: Asia-Pacific is expected to see the fastest growth in the forecast period.

    The antibody discovery market is poised for significant growth driven by advancements in precision therapeutics, innovative technologies, and strategic acquisitions. With increasing investments in R&D and a growing demand for targeted therapies, the market is set to expand rapidly in the coming years.

    Request A Sample Of The Global Antibody Discovery Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13783&type=smp

  • Global Advanced Therapeutics Pharmaceutical Outsourcing Market Key Insights 2024-2033

    Global Advanced Therapeutics Pharmaceutical Outsourcing Market Key Insights 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Advanced Therapeutics Pharmaceutical Outsourcing Global Market Report 2024, the advanced therapeutics pharmaceutical outsourcing market is expected to show promising growth in the forecast period.

    Market Expansion Overview

    • 2023 Market Size: $7.64 billion
    • 2024 Market Size: $8.07 billion
    • CAGR: 5.6%

    The advanced therapeutics pharmaceutical outsourcing market has seen significant growth, driven by the expansion of biopharmaceutical infrastructure, regulatory compliance, demand for novel drugs, improved efficiency, and personalized medicine.

    Future Market Projections

    • 2028 Market Size: $9.76 billion
    • CAGR:9%

    Steady growth is expected due to increased adoption of cell and gene therapies, focus on mRNA therapies, demand for cutting-edge treatments, cost-effective outsourcing solutions, and collaborative innovation. Trends include technological advancement, expertise in advanced therapeutics, innovative therapy pipelines, and rapid advancements in gene, cell, and mRNA technologies.

    View More On The Advanced Therapeutics Pharmaceutical Outsourcing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/advanced-therapeutics-pharmaceutical-outsourcing-global-market-report

    Impact of Cell and Gene Therapies

    • Increase in Gene Therapy Patients: From 16,244 in 2020 to 94,696 in 2025

    The adoption of cell and gene therapies is driving market growth. These therapies use living cells or genetic material to treat diseases, with outsourcing providing access to experienced providers. According to a 2023 Nature report, the number of patients treated with gene therapies is expected to increase significantly by 2025.

    Key Market Players

    • Major Companies: Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Croda International Plc, Samsung Biologics.

    Strategic Partnerships

    • Example Partnership: Lonza and Context Therapeutics Inc. (January 2023)

    Companies are forming strategic partnerships to provide reliable services. For example, Lonza partnered with Context Therapeutics Inc. to offer manufacturability assessment, gene and cell line construction, and process development for drug substances and products.

    Acquisitions and Expansions

    • Notable Acquisition: Catalent Inc. acquires Metrics Contract Services and CDMO (August 2022)

    Catalent Inc. acquired Metrics Contract Services and CDMO for $475 million to enhance its capabilities in oral solid formulation development, manufacturing, and packaging, helping customers accelerate their programs and handle potent compounds.

    Market Segmentation

    • By Service Type: Contract Research Organizations (CROs), Contract Development and Manufacturing Organizations (CDMOs)
    • By Indication: Oncology, Neurology, Cardiology, Infectious Diseases, Other Indications
    • By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
    • By Application: Preclinical Services, Clinical Services, Commercial Manufacturing and Packaging

    Regional Insights

    • Largest Market in 2023: North America

    The advanced therapeutics pharmaceutical outsourcing market is segmented by service type, indication, therapy, and application, with North America leading the market in 2023 due to its advanced infrastructure and high adoption of innovative therapies.

    Request A Sample Of The Global Advanced Therapeutics Pharmaceutical Outsourcing Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=13768&type=smp